secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001628280-25-005308
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners provides preliminary 2025 guidance; proposes $30M note from largest shareholder
--------------------------------------------------------------------------------

- Preliminary 2025 revenue guidance of $1.35B-$1.5B; Adjusted EBITDA of $(35)M to $5M.
- At-risk members guidance of 108k-118k for FY2025.
- Proposed $30M unsecured promissory note and warrants from largest shareholder, terms similar to Dec 2024 financing.
- CEO states $130M+ EBITDA growth initiatives on track; targeting profitability in 2025.
- Full 2025 guidance to be issued with Q4 2024 earnings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828025005308/0001628280-25-005308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828025005308/piii-20250213.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-005308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer